Fidson Begins Study For WHO Prequalification On Albendazole

Fidson Healthcare Plc, one of Nigeria’s foremost pharmaceutical companies, has announced a strategic partnership with Liddie BE Limited, a renowned clinical research organisation, to conduct a Bioequivalence (BE) study on their chewable formulation of Albendazole tablets. The founder and Chief Executive Officer (CEO) of Fidson Healthcare Plc, Dr. Fidelis Ayebae, who announced the study at...The post Fidson Begins Study For WHO Prequalification On Albendazole first appeared on New Telegraph.The post Fidson Begins Study For WHO Prequalification On Albendazole appeared first on New Telegraph.

Read More